NasdaqGM - Delayed Quote USD

TriSalus Life Sciences, Inc. (TLSIW)

Compare
1.1200
+0.0200
+(1.82%)
At close: January 30 at 4:00:00 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-43,780.0000
-50,045.0000
-32,313.0000
-22,697.0000
Investing Cash Flow
-1,200.0000
-2,121.0000
-1,786.0000
-2,258.0000
Financing Cash Flow
34,985.0000
54,629.0000
13,462.0000
50,768.0000
End Cash Position
11,638.0000
12,127.0000
9,664.0000
30,301.0000
Income Tax Paid Supplemental Data
--
14.0000
9.0000
3.0000
Interest Paid Supplemental Data
--
--
--
18.0000
Capital Expenditure
-1,200.0000
-1,121.0000
-786.0000
-1,258.0000
Issuance of Capital Stock
2,956.0000
9,189.0000
13,499.0000
52,017.0000
Issuance of Debt
--
--
--
45.0000
Repayment of Debt
-87.0000
-87.0000
-131.0000
-1,348.0000
Free Cash Flow
-44,980.0000
-51,166.0000
-33,099.0000
-23,955.0000
12/31/2021 - 2/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade